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Of#&es. We songbt to de&ne the e&c& of short-term bcta- 
adrenergic blocking medication on intmcoronary flow chatter- 
istics, clinical symptoms and angiagmpbic dhmeter clramges in 
patients with severe qpcardM bridging of the teft aoteriar 
descendiRg eoronarp artery 
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Myocardiai bridging is anatomically defined by the intramyo- 
cardial course of portions of the coronary arteries, mainly the 
midportion of the left anterior descending coronary artery (1). 
Its typical angiographic presentation is the q&ok “millring’ 
effect due to transient myocardial vessel compression (2.3). 
The reported frequency of this anomaly varies widely, from 
15% to 85% at autopsy and 0.5% to 16% on angiogmphy 
(4-7). There is also cousiderable controversy regarding the 
clinicaIl, hemodynamic and proguostic sign&awe of myocar- 
dial muscle bridges. Although various reports are available 
descriiing ischemia (S), mywardiai infarction (9-l l), ar&yth- 
mia (12,13) or sudden ~rdiac death (14-16) in association 
with this anatomic variation and otbenvise normal coronary 
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Table 1. Demographic and Clinical Characteristia in 15 Patients 
Witb Myocardial Bridging 
Age 0 
Mean+SD 52.6 2 6.8 
Range 39-63 
Male 13 (87%) 
Interval (mo) 
Meaa+SD 19.7 + 21 
1-88 
2.5 c 1.3 
l-4 
15 (loo%) 
10 (67%) 
ti 5 (33%) 
cc3 cIa.s 
II 5 (33%) 
111 6 (40%) 
Iv 4 (27%) 
Ergomeny (to=4 11(73%) 
Positive 7 (47%) 
Myocmdial scintigraphy (total) 8 (53%) 
Positive 5 (33%) 
‘The intewd from tkst symptoms to aogiogtapbic diagnosis of myowdiil 
bridging. tDae to aagiaal symptoms Unless othenwk indiited, data presented 
are number (%) of patients. CCS = Caoadii Cardiiovascular Society (foocttioal 
damiIicalion of aagiaa). 
tale and diastole within the mvocardial bridge. 2) to determine 
the degree of flow acceleratioi within the m&akiai bridge at 
rest aad during rapid atrial pacing, and 3) to study the short- 
term effect of intravenous beta-adrenergic blocking agent 
administration on angiographic lumen diameter reduction, 
inmmcmary Doppler flow velocities, clinical symptoms and 
electrocardiogmphic signs of &hernia. 
M&ho& 
Patieat selection aod cImwtdslica. Fifteen patients with 
an anghppkcally docmented myoca&al bridge of the 1ef1 
anterior descending coronary artery with a >70% systolic 
hmten diameter reduction were sekctively studied (mean age 
52.6 2 6.8 years; 13 male [87%]). Evidence of coronary artesy 
disease ~a.9 excluded by selective coronary angiography. 
Global if& ventriadar fimctbn was normal in d patients In 
addition, there were no signs of left veotricular hypertroptn or 
lymtmphied cardiomyopathy. ‘Ihree patients had a history of 
mild hypertension without echoca&grapbic evidence of left 
ventricular hype-y. The major demogmphic and clinical 
ClbaraEteristics are giveo in Table 1. All patients reported a 
historyofcbestpainstronglysugge&eofanginapectork.Tbe 
ruemtio3eintewaibetweenthefir8tsymptmsandtbeaugio- 
graphicdiagnosisofantyocardialmuscIebridgewas19.7~21 
otmtk R&t of the patienta had several previous hospital . . 
-owing~angiaapectoris~suspeaed-w+ 
CIOdildiIIfWh$Orboth.TbreepatientshttdprwiomiDtN- 
~~~~~~~~~~ 
ehtionio . . enzymesand- 
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(ECG) abnormalities without Q waves. Symptom-limited ex- 
ercise ECGs were available in 11 (73%) of 15 patients. Four 
patients did not undergo stress testing before cardiac catheter- 
ization because of unstable symptoms (Canadian Cardiovascu- 
lar Society functional class IV) or rest ECG abnormalities. 
Significant ischemic ST segment depression of more than 
0.1 mV in the anterior leads were identified in 7 (64%) of 11 
patients. In addition, 5 (63%) of 8 patients with planar thallium 
201 sciotigraphy demonstrated reversible perfusion defects in 
the anterior-septal wall. Three patients (20%) had no signs of 
ischemia at rest or during stress testing, but reported long- 
standing and recurrent chest pain with relief after nitrate 
administration. Informed written consent was obtained from 
all patients. 
Anglography. Before cardiac catheterization all cardiovas- 
cular medications were withheld for at least 24 h. Cineventric- 
ulography and selective coronary angiography were performed 
using the J&ins catheter technique in multiple standard 
projections. Cioeangiograms were recorded with 25 frames per 
second on 35-mm film. 
Quantitative corooary angiography. A 35-mm cineprojec- 
tar with an adapted videocamera (CAP 35 BII) was used to 
visualize the left anterior descending coronary artery. The 
video signal was then digitixed (512 X 512 pixels) for quanti- 
tative measurements on a workstation with dedicated software 
(AWOS vs. 4.1, Siemens Erlangen, Germany). For this pur- 
pose the coronary segment of interest, including the total 
length of the myocardial bridge with the adjacent nonob- 
strutted proximal and distal segments, was identified. Bound- 
aries of this segment were then detected automatically and 
corrected manually if necessary (Fig. 1). Absolute vessel 
diameters (mm) were determined using the guiding catheter as 
a reference. The percent diameter stenosis at the most severe 
site was automatically calculatep from the comlkter estimatioo 
of the origin~‘dimension of the artery along the myocardial 
bridge, defined as an interpolation between proximal and distal 
reference diameters. Angiographic lumen diameter evaluation 
was performed at end systole, when the diameter of the vessel 
was smaksi, and &ring mid-diastolic frames. To dete.rmine 
interobserver variability for quantitative angiographic mea- 
surements of systolic and diastolic lumen diameter reductions, 
images from a random subset of, 10 patients were analyxed by 
IWO independent observers (E.RS. and H.GK.) blinded to 
each otheis results. Iowrver variability was measured by 
having one observer (E.R.S.) analyze the same angiographic 
images ou two separate occasions, blinded to bis previous 
results. Iotehrver correlation co&&n& for the absolute 
augiqppbic systolic and diasioiic lumea diameters within the 
muscle bridge was r = 0.91 with a standard error of the esti- 
mate (SEE) of 0.06 mm; for percent lumen diameter reduc- 
tion, r = 0.92 (SEE 4%). The inlraobserver variability for 
absdute systolic and dii dimensions within the myocar- 
dial bridge was r = 0.95 (SEE 0.05 mm), and r = 0.98 (SEE 
2%) for the percen? diameter ledu&nl 
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Fire 1. Digitized and magnified angiographii 
images of the midportinn of the left anterior 
descending coronary artery. The boundaries of the 
coronary muscle bridge, including a proximal 
(Prox) and distal (Diit) segment without compres- 
sion, are delineated during diile (A) and systole 
(8). The graphs to the lower right rekct the- 
quantitative analysis of the identified vessel seg- 
merits. The absolute values are given in the t&k 
to the upped right. A = area; Cal = calibration; 
Ce = resistance c&licient; Cv = viscose resis- 
tance ooetlicient; D = diameter, Dens = densiT, 
Dn = normal diameter, L = segment length; 
Min = minimal; Norm = normal; pix = pixel; 
Red = reduction; SFR = stenosis flow reserve. 
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measurementswereperformedwitha commercialiyavailabk lImmwu+gaidaweaodpheedint&egefteM 
Doppler guide wire (Flowire, cardiometrics Inc.) using stan- ingcomWyartely.#rewas~tooriestthe~~ifJthe 
dardtechniques.In brief,after i3dlcaationof5,muof centerofthevesdtoobtain 
heparinsodiumin~~,tbehighly~tlexiMerindsteerable veioeityenvelope.TBcfdlolviog 
0.014-k (0.035 cm) an@opWy guide wire with a 12-b&k calculatedbyintegrated~fFomtwocoaseartivebeats 
ultrasoundtransducermountedonits*wasadvanced& avmgepeakfIowveiorhyaveragediBadizpeakBav~ 
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Table 2 Comparison of Quantitative Comnary Aagiographic 
Measurements in 15 Patients With Myocardial Bridging at Bascliue 
and After Beta-Blocker Medication 
Cardiac Catheterization 
Baseline After Bela-Bkxker 
(n=15) (n = IS) p Value 
Conwary diameter (mm) 
Pmsimrd to MB 
systdii 2.12 0.5 25 ?r 0.7 NS 
LXastolic 26 2 0.5 2.6 + 0.5 NS 
OistaltoMB 
Systolic 2.2 + 0.4 2.0 + 0.4 NS 
Diartolic 2.4 2 0.4 2.3 2 0.4 NS 
WiiMEt 
SjSlOliC G.-I 5 0.3 1.0 i- 0.4 < 0.01 
DiastoIic 1.7 f 0.3 1.9 2 0.3 < 0.0’ 
LengthofW(mN 
S@diC 27.4 2 7.9 22.8 2 5.0 < 0.05 
DiSKdiC 25.2 2 45 22.8 -t 5.6 < 0.05 
% diameter redurtiotl 
systolic 829 + 9.4 61.8 2 11.4 c 0.001 
Diastdic 9 7 2 10.9 29.8 2 9.0 c 0.001 
MB=mymrdidbridge. 
average systolic peak flow velocity, maximal peak flow velocity 
(in an/s); and diitoliisystotic flow velocity ratio. 
Stsdy pmtml After routine coronary angiography, right 
atriai pacing was performed to determine the indiidual 
Wenckebach point. Baseline Sow velocity measurements were 
cbtahed proximal to, within and distal to the myocardiil 
bridge. Cornnary liow reserve meaaurementa were obtained in 
12 (80%) of 1.5 patients after intracoronary injection of 10 to 
12 mg of papaverine, placing the transducer proximal and 
distal to the myocardial bridge. Coronary flow reserve was 
ffied as khe ratio of mean flow veiocity achkved at peak 
hyperemia to the meau rest Sow velocity. The remaining three 
patients had prolongation of their QT interval at basetii, and 
to avoid arrhykk complications (i.e., ventricular tacbycar- 
dia), papavmine was mt adminihtered to these patients (30). 
Atrialpacingwasstartedwithaheartrateof80beat&niuand 
iInxewdby2Obeatsevely2tiuntiltbepaciagfatewas5 
beats below the predetermined Wenckebach point. At the 
maximal heart rate, Doppler flow velocities were again re- 
cordedfromthesamesegmentsdistalandproximaltothe 
mymMiafbridge.After15minofrecoverythesamepacing 
protoxdwaampeated,andatthemasimalheartrateabody 
weight-a@tedbohrsinjectionof5Otl&kgover6Osofthe 
be-t esmoloi (Gensia Europe Lid., Bracknetl, En- 
~~UK)~staned,followedbyamntinuMlsinfusionof50 
to5oo&kgpermiIbtGJmingwiththeioweatdoseandtheBan 
iocrertseevery2minupt0themaximaidoseina5patientsln 
a5 pathts a 12-kad ECG was recorded Immediatefy after 
diecoatinuhlg atrial pacing and removing the Doppler guide 
~~~~~~~~~~rn~ 
tudemminetumea-dhaoges. 
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El 2 Scatterpnt showiug the individual changes in percent 
systolic and diastolic lumen diameter reductions using quantitative 
coronary angiography at baseliue and during beta-blocker mediition. 
Only one patient showed no reaction after beta-blocker adw.nistra- 
tion. 
were compared by analysis of variance for repeated measure- 
ments. Relations between groups were studied using the paired 
Student t test: a Bonferroni correction was appIied to adjust for 
multiple comparisons. A p value ~0.05 was considered statis- 
tically signihcant. 
Results 
Qnantitntive angiagraphtc measnrements. The complete 
quantitative coronary angiographic data are presented in Table 
2. The mean percent diameter reduction at the most severe 
side of the myocardial bridge during systole was 83 2 %, 
ranging from 71% to 99%. There was a persistent diastolic 
lumen diameter reduction of 41 + 11% with a minimum of 
24% and a maximum of 58%. The mean absolute systolic 
diameter within the myocardial bridge was 0.7 -C 0.3 mm; tive 
patients bad a miniial diameter ~0.5 mm. The length of the 
myocardial bridge during systde ranged from 19 to 44 mm 
(mean 27 2 8) and was not diierent from the diastolic values 
of 25 ? 5 mm (range 21 to 42, p = NS). Shot. .,rm iutravenous 
beta-blocker administration induced a 25% decrease in mean 
percent @olic diameter reduction within the myocardiai 
bridge, from 83 ? 9% to 62 z? 11% @ < 0.091) (range 47% to 
86%), immediitely after tacbypac& There was a similar 25% 
change in diasdic diameter reduct& from 41 2 11% to 30 2 
9% @ < 0.091) (raoge 14% to 53%) (Fii 2). The absolute 
diameter within the myocmhl bridge increa& from 0.7 2 
0.3 to 1.0 f 0.4 mm @ < 0.01) during systofe and from 1.7 + 
0.3 to 1.9 2 0.3 mm (p < 0.01) during diastole. There were no 
sign&antchangesinthesegmentspnwimalanddistaltotbe 
myocanMbridge.fnadalition,thekngthofthemyocanM 
blidgeduringsycoleanddiItst&deaeasedslightly,fmm 
n+8to23+5mm(pc0.05)andfrom~It5toZ3’,6mnr 
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Fii3. Box plots dfmoastratiag intracoronary Doppler flav veloc- 
itiesproximalto,withinanddislaltothemyccanMmmclebrid8eat 
restaaddariagatrialW@paciq(meaaheartrate134beat&aia)a0d 
additional beta-bbcker medication with cantinuing taehyeardia. & 
Average peak tlow velocity. it, Average diastolii peak tlow v&city. C 
Diit01ic/yst0lic flow velocity ratio. 
(p < OM), rqwtively. Only one patient showed no angio- 
graphic reaction during beta-blockade. 
ln~DoQBkr8nw~-cs.‘4frest 
withameanheartra~of75 2 7beatslmin,theaveragepeak 
(26.7 + 9.6 cm.@ and diastolic peak (33.1 2 13.4 an/s) aow 
velocities were signihntly higher within the bridged segment 
than the ‘pmximal (21.2 2 7.4 cm/s Ip c O.OOl] and 255 f 
13.3 cm/s [p < 0.011, reqkxtiveiy) and distal segments (143 2 
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3.2 cm/s and 16.5 t 316 cm/s [p < O.OOl], respectively) (Fig. 3A, 
B). The flow velocity increase within the myocardial bridge was 
smallest for the average systolic peak flow velocity, with 12.3 ? 
4.6 cm/s proximal to, 13.7 5 6.6 cm/s within (p = NS, 
compared with proumal) and 9.1 5 2.3 cm/s distal to the 
myocardial bridge (p < 0.05, compared with the bridged 
segment). The instantaneous maximal peak Ilow velocity was 
more than twice as high within (78.1 2 21.1 an/s) ascompared 
with proximal (315 + 13.5 cm/s Ip < O.OOl]) and distal (24.3 2 
11.6 cm/s [p -C O.OOl]) to the myocxdial bridge. The diasMc/ 
systolic flow velocity ratio at rest was not different between the 
three measuring points (Fig. 3C). There were also no signifi- 
cant differences comparing all flow velocity measurements 
proximal and distal to the myocardial bridge. 
Tuehpcing with a mean heart rate of I34 f I2 beaWmin 
induced aa increase of all flow velocities within the myocardii 
bridge (Fig. 3 [A and B] and 4). Ihe average diactolic peak 
flow vehxity increased from 29.1 2 12.2 cm/s prox&l and 
20.2 2 4.2 cm/s distal to 633 2 213 cm/s (p < 0.001) within the 
myocardial bridge (Fii 3B). Ihe tlow acceleration was largest 
for the maximal peak tlow velocity, from 34.4 2 8 cm/s 
proximai end 27.8 2 8.4 cm/s distal to 104.8 i 35.7 cm/s (p < 
0.001) within the bridge. The increase was again smallest for 
the average systolic peak flow velocity, with 10.9 + 3.4 cm!s 
proximalaad9.1t4cmkdistalversus162~7em/s@< 
0.05) withm the bridged segment The calcoiated diastoW 
systolicflowvelocityratio~anddistaltothcmyocar- 
dial bridge was not ditferent during atrial pacing. There wx, 
however, a sigo&aot change in the diastolic&stolic flow 
velocity ratio within the myocardii bridge daring tachycardia, 
w~khwasootpresentatrest(2.4rl.Ovs4.9+29~[p< 
O.Ool]) (Fig. 3c). Tllere were no sign&ant changes ill flow 
Wlocitiesfromresttop;sciog~aoddistaltothe 
myocdhlbridge.Duringtachypecingaapatientsreported 
mild dyspnea; 9 (64%) of 15 patients developed qinal 
sjlnptomscomparablewiththeirusualdiniicomplaints;rmd 
6(43%)hadcorreqmdi@TsegmentchaqesinUXileads 
V,toV,orlandaVL 
flaw- *=- 
llowreserWproGmaltothernyWMalbridgewas2.7r 
0.8 an/s and bi$tm than measlliementsabtainedalirtalto(ihe 
bridge (20 2 0.6 at& [p < 0.011). A ratio >3.0 was obtGned 
itl25%OfpBt&SWitll mePaueraentsobtainedpmrdmalt0 
andinoonewith measnrernents-dktaltO?hCmpar- 
dialbridge. 
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Flgore 5. Scattergram demonstrating the individual changes in aver- 
age diastolic pe.lk Row velocity from baseline to atria1 pacing (mean 
heart rate 134 beats/min) and during beta-blocker medication. Only 
one patient showed no reaction after the maximal beta-blocker dose. 
Beta-blue& e&t on Doppler Row velocities, electracar- 
&graphic abnormalities and symptnma Initially, there was a 
slight drop in the mean arterial blood pressure (from 76 2 
8 mm Hg to 67 L 4 mm Hg [p < 0.051) after the b&s 
administration of esmolol, but the pressure returned to base- 
line values after 5 min despite continuous beta-blocker infu- 
sion. All Doppler flow velocities within the myocardial bridge 
returned to baseline values during beta-blocker medication, 
&spite persistent tachypacing with a mean heart rate of I34 2 
12 beats/min (Fig. 3 to 6). The mean drop in average peak flow 
velocity within the myocardi2il bridge was 3% (from 44.9 2 
15.1 to 27.2 -C 11.7 cm/s [p < O.OUl]), and 46% for the average 
diastolic peak flow velocity (from 63.3 2 21.3 to 34.5 2 
16.4 cm/s [p < O.OOl]). A similar decrease (42%) occurred for 
the maximal peak flow velocity (104.8 2 35.7 vs. 60.5 2 
26.5 cm/s ip < O.OOl]). There were no sign&ant changes in 
flow velocities proximal and distal to the bridged segment 
during beta-blocker medication. With increasing doses of 
beta-blocker, symptoms vanished in 8 (89%) of 9 patients, and 
KG changes normalized in 5 (83%) of 6 patients (Fig. 7). 
Only one patient reported no improvement at all; the same 
patient showed no changes in angiographii diameter reduction 
(86% at baseline and 85% after beta-blocker administration) 
and only a minimal decrease in Doppler tlow velocities (aver- 
age peak flow velocity at rest 42.8 cm/s, during tachypacing 
66 cm/s and with beta-blockade 63 cm/s), despite a maximal 
beta-blocker dose. 
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Figore 6. Trend display of the average peak flow velocity within the 
myccardial bridge. Atriai pacing induces aa abrupt increase in flow 
velocities, with a gradual decline during increasing doses of beta- 
blocker with continuing tachypacing. Asterisks indicate contrast injec- 
tions inducing a short flow acceleration. 
a significant reduction in Doppler flow velocities with return to 
baseline values and normalization of the diastolic/systolic flow 
velocity ratio within the bridged segments. Coronary angio- 
grams obtained immediately after pacing and beta-blocker 
administration revealed a more than 25% increase in systolic 
and especially diastolic lumen diameter within the myocardial 
bridges. There was also a clear symptomatic improvement in 
those patients developing angina during pacing and normal- 
ization of stress-induced ECG ST segment changes. Myocar- 
dial b&iges have long been considered as harmless anatomic 
variants, raven though serious cardiac events have been de- 
scribed in association with this angiographic entity in the 
absence of coronary artery disease (14). The major objective of 
the present study was to obtain further insight into the 
ischemic mechanisms and potential therapeutic strategies in 
myocardial bridges utilizing new miniaturized intracoronary 
Doppler technology combined with standard quantitative an- 
giography. A series of IS patients with an angiographically 
proven myocardial bridge of at least 70% systolic lumen 
diameter reduction was selected. All patients had a history of 
chest pain with repeated episodes of hospital admissions owing 
to unstable symptoms, including three patients with intramural 
anterior wall myorardial infarctions but with normal global left 
ventricular function. Based on these inclusion criteria, the 
present study group is not necessarily a representative selec- 
tion of the general population of patients with myocardial 
bridges, in whom the ang&raphii diagnosis is often com- 
pletely incidental, but rather may reflect the negative angio- 
graphic and symptomatic variants of thii entity. 
pbic 6ndii The mean degree of systolic lumen 
diam+r reduction obtabxd by single-plane quantitative CoT- 
0~ aogiopphy was 83%, which is more severe than the 
Discussion 
The present study demonstrates that intravenous injection 
of a short-acting beta-blocker (esmolol) during ta&ypacing in 
~~~~~~~rn~~b~~~ 
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Figare 7. Electnxardiiaphic tracings from a patient 
with q yecardial bridging of the left anterior descend- 
ing coromy artery. A, During atrial pacing (mean 
heart rate 140 b&s/min), demonstrating ST segment 
depression (0.1 mV) in leads V, to V,. B, Tachypa&g 
with intravenous admiition of the beta-blocking 
agent esmolol aad a near-normal el&mcardiogram 
with less ST segment depression. 
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redurtions reported in most previous series (6,26). In addition, 
there was a persistent diastolic narrowing of 41%, as de&bed 
previously by Ge et al. (2621) using intravascular ultrasound in 
less severe cases of myocardial bridging, most probably caused 
by a delayed diastolic relaxation within the bridged segment. 
‘Ike length of the myocardial bridge (mean 23 mm) was 
consistent with data published previously (20). 
Intrac~~ronary Doppler Bow measurements revealed a sig- 
niiicant increase in average peak, diastolic peak and maximal 
instautaneous peak flow velocities within the myocardial 
bridge at rest, with only minor changes in systolic flow. Atrial 
pacing induced a further acceleration in flow velocities within 
the bridged segment, whereas the flow vek&ies proximal and 
distal to the myocardial bridge remained unchanged. A signif- 
icant increase in tbe diastolic&tolic flow velocity ratio ap- 
pears to be the most prominent flow alteration within the 
myocan&l bridge during stress. 
contiarvgk- The coronaty flow reserve deter- 
mined proximal to the myocardial bridge was normal or slightly 
reduced, with a mean ratio of 2.7 (non@ >3.0). Measure- 
ments distal to the myocaniiai bridge, however, revealed an 
impaired flow reserve, with a mean ratio of 2.0. This phenom- 
enon can be explained by tbe reduced mid- to late diastolic 
flow velocity, as stated previousIy by Cie et al. (26). Because of 
the varyhg length of the m-dial bridges (27 t 8 mm), 
septaI perforators and diagonal branches may have originated 
between the proximal and distal guide wire positions, explain- 
iug the bigher proximal llow reserve. We disregarded coronary 
llow reserve mcasuremens withiu the myvmrw bridge be- 
cause of tbe elevated basic Row velccity and the often largely 
distorted arm velocity pmlik obtaiucd iu this positiort. These 
fkdiiofIxdmxdmronaryfIowreseIvebltheabsence0f 
coronaqarterydiseasecanbeexplakdbyahemodynamieallv 
sign&amtlIowobstr&onwitbincrea&resk&ceowingt~ 
themyoeardiaibridge,asrccently -tedbyiu~ 
naryprqsurenx4mSngina&ngIecasewitbasystoIic- 
dkstolkprcaslue~ntbetweentIle~aBddistal 
t of the myonudiai btidge (32). km&r kporta@ 
mechanism, besides systolic vessel compression, is a delayed 
earIy and mid-diastolic relaxation with increased diastolic fIow 
velocities, as also shown by Ck et al. (26). 
CIiiical iaiqlkatibos. The occurrence of angina pectoris, 
myocardial infarctions and arrhythmias in many patients with 
myocardial bridges may therefore be explained by the reduced 
ischemic threshold. Tkrapeutic strategies in symptomatic 
patients with a myocardial bridge have been extremely diverse, 
iuchtding surgical myotomy (33-37), cdciutt chanoel antago- 
nists (38) and lhSHockcrs (39), mainly because of our poor 
uttderstanding of the underlying pathopbysiologic mecha- 
nisms. Nitrates have been used effectively in XXIX of these 
patients, although it is a well-kmxvn phenomenon that acute 
nitrate application, intraaxonariiy or sublingually, during cor- 
onaryan@graphyimxeasestheaq&qbicdegreeofsys- 
toIic~andshouldIeadtoaworseningofqmptoms 
(17,19,40,41). Tbe benelkial effect of nitrates may therefore 
ootbebasedoovarodilatioo,butonaredudioninpteload~ 
espe&dyantivasqastkcapabiitieqamechanismthathas 
beendeacrkdrepeatedlyascausingsymptomsinmpcardial 
bridges (19,40). Gmsidcring the bask mt!dnkm of OhstNc- 
tion,thereisakosomepatbophysKdogicratkmaiefortbeuse 
0fbeta-bloctingagen~mainIyowingtotbeirwgative~ 
tropicandchronotropiceff~arhichsbotddleadtoareduc- 
tioninexternalrimxuIarcompre;riooandaprobagatioaof 
dit&oucpelfusioBintervals.Thbimprovemen tisasaiitable 
to the negative inotropic et&t of the beta-block@ agenl with 
areductioninmaximal+oIicandpers&tentdiastokvcsvl 
comprcssionassbown~andacaocomitant 
redudioniocoronarytlowveIocitkwitbinthebtidgedsq- 
ment.Atladditioaal~ trtpmmmtcaRheerpectedfrointbe 
negative&onot+cetkztofesmdd,whicbwasm&ediri 
mtrstudydesigoowingtomtttiauousatriat~Pr~- 
tiooofd&oIewithar&ctioninpers&entlumen z (18), bawever, may be an add&ml e - 
nimbywhichtoreducethe~iIlaueuceormyo- 
cardialbridg&Areceutax&ined~arzularukaxnmd 
adquantitative~ studyhasshowntbBt 
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there is only a modest correlation between the two techniques 
in measuring the degree of systolic/diastolic lumen diameter 
reduction within the myocardial bridge (26). On the other 
hand, the Doppler guide wire with a cross-sectional area of 
0.16 mm* offers the unique opportunity to evaluate flow 
velocities accurately, even deep within the coronary arteries 
without flow obstruction by the wire itself (42). 
Study limitations. We inchtded a limited number of pa- 
tients, all of whom had long-standing symptoms and severe 
systolic vessel compression. Objective signs of ischemia could 
not be demonstrated in all of our patients. This is a well-known 
phenomenon in myocardial bridging, most likely because of a 
large spontaneous variability in clinical symptoms and angio- 
graphic severity of lumen obstruction (17). Our results may 
therefore not be directly extrapolated to a larger population of 
patients with myocardial bridging. No atherosclerotic lesions 
were found in these patients angiographically. However, we 
were not able to exclude small plaque formations only detect- 
able by intravascular ultrasouud (26). Tachypacing is a subop- 
timal type of stress with a minor increase in contractility, blood 
pressure and cardiac output; more severe effects can bc 
expected from dynamic stress modalities. Coronaty flow re- 
serve measurements were not repeated during and after beta- 
blockade. A systematic evaluation of diameter changes 
throughout the complete cardiic cycle has not been per- 
formed, although the delay in early and mid-diastolic lumen 
diameter gains may represent the most prominent pathophys- 
iologic mechanism causing the described hemodynamic 
changes. 
Cmmlnaiis. Myocardial bridging can cause ischemia and 
related clinical events if the systolic vessel compression is 
severe (: 70%) angiographicalfy (6). Blood flow velocity is 
increased within the bridged segment, especially during tachy- 
cardii with concomitant anginal symptoms. Beta-blocking 
agents given during tachypacing demonstrate the capability to 
increase the maximal systoiii as well as diastolic diameters and 
to reduce tlow velocities to normal, with disappearance of 
symptoms and ST segment changes in the ECG. Therefore, in 
patients with myocardii bridging and severe symptoms, intra- 
venous beta-blocker administration appears to be a reasonable 
therapeutical approach. Further studies are necessary to eval- 
uate the long-term eificacy of beta-blocker therapy. 
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